{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T03:43:54Z","timestamp":1782963834533,"version":"3.54.5"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T00:00:00Z","timestamp":1778284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T00:00:00Z","timestamp":1782950400000},"content-version":"vor","delay-in-days":54,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-026-05067-0","type":"journal-article","created":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T16:06:57Z","timestamp":1778342817000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Identification of biomarkers associated with diagnosis of gastroesophageal junction adenocarcinoma and their correlation with immune infiltration"],"prefix":"10.1007","volume":"17","author":[{"given":"Jianfu","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aimin","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junli","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingxiao","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaohui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,9]]},"reference":[{"issue":"7","key":"5067_CR1","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1200\/jco.2009.27.5644","volume":"1","author":"MF Press","year":"2011","unstructured":"Press MF, Sauter G, Buyse M, et al. Alteration of topoisomerase II-alpha gene in human breast cancer: association with responsiveness to anthracycline-based chemotherapy. J Clin Oncol. 2011;1(7):859\u201367. https:\/\/doi.org\/10.1200\/jco.2009.27.5644.","journal-title":"J Clin Oncol"},{"key":"5067_CR2","doi-asserted-by":"publisher","DOI":"10.1177\/1758835919897543","volume":"11","author":"J Peng","year":"2019","unstructured":"Peng J, Ou Q, Deng Y, et al. TROP2 overexpression in colorectal liver oligometastases is associated with poor prognosis after liver resection. Ther Adv Med Oncol. 2019;11:1758835919897543. https:\/\/doi.org\/10.1177\/1758835919897543.","journal-title":"Ther Adv Med Oncol"},{"issue":"1","key":"5067_CR3","doi-asserted-by":"publisher","DOI":"10.1186\/s40425-019-0594-0","volume":"7","author":"HL Kaufman","year":"2019","unstructured":"Kaufman HL, Atkins MB, Subedi P, et al. The promise of immuno-oncology: implications for defining the value of cancer treatment. J Immunother Cancer. 2019;7(1):129. https:\/\/doi.org\/10.1186\/s40425-019-0594-0.","journal-title":"J Immunother Cancer"},{"issue":"2","key":"5067_CR4","doi-asserted-by":"publisher","first-page":"147","DOI":"10.2174\/0115665232247694230921060213","volume":"24","author":"K Wang","year":"2024","unstructured":"Wang K, Yu Y, Zhao J, et al. A retrospective analysis of the Lauren classification in the choice of XELOX or SOX as an adjuvant chemotherapy for gastric cancer. Curr Gene Ther. 2024;24(2):147\u201358. https:\/\/doi.org\/10.2174\/0115665232247694230921060213.","journal-title":"Curr Gene Ther"},{"issue":"10","key":"5067_CR5","doi-asserted-by":"publisher","first-page":"282","DOI":"10.4251\/wjgo.v10.i10.282","volume":"10","author":"JL Leiting","year":"2018","unstructured":"Leiting JL, Grotz TE. Optimizing outcomes for patients with gastric cancer peritoneal carcinomatosis. World J Gastrointest Oncol. 2018;10(10):282\u20139. https:\/\/doi.org\/10.4251\/wjgo.v10.i10.282.","journal-title":"World J Gastrointest Oncol"},{"issue":"3","key":"5067_CR6","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1002\/(SICI)1097-0142(20000201)88:3<577::AID-CNCR13>3.0.CO;2-V","volume":"88","author":"S Ishigami","year":"2000","unstructured":"Ishigami S, Natsugoe S, Tokuda K, et al. Prognostic value of intratumoral natural killer cells in gastric carcinoma. Cancer. 2000;88(3):577\u201383. PMID: 10649250","journal-title":"Cancer"},{"issue":"5","key":"5067_CR7","doi-asserted-by":"publisher","first-page":"2359","DOI":"10.7314\/APJCP.2014.15.5.2359","volume":"15","author":"M Hong","year":"2014","unstructured":"Hong M, Jiang Z, Zhou YF. Effects of thermotherapy on Th1\/Th2 cells in esophageal cancer patients treated with radiotherapy. Asian Pac J Cancer Prev. 2014;15(5):2359\u201362. https:\/\/doi.org\/10.7314\/APJCP.2014.15.5.2359.","journal-title":"Asian Pac J Cancer Prev"},{"issue":"8","key":"5067_CR8","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.1386","volume":"13","author":"J Li","year":"2023","unstructured":"Li J, Sun J, Zeng Z, et al. Tumour-associated macrophages in gastric cancer: from function and mechanism to application. Clin Transl Med. 2023;13(8):e1386. https:\/\/doi.org\/10.1002\/ctm2.1386.","journal-title":"Clin Transl Med"},{"key":"5067_CR9","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1497783","volume":"15","author":"H Wang","year":"2024","unstructured":"Wang H, Li J, Wang Y, et al. IgG4-mediated M2 macrophage polarization in tertiary lymphoid structures of esophageal cancer: implications for immunosuppression. Front Immunol. 2024;15:1497783. https:\/\/doi.org\/10.3389\/fimmu.2024.1497783.","journal-title":"Front Immunol"},{"issue":"5","key":"5067_CR10","doi-asserted-by":"publisher","first-page":"390","DOI":"10.2174\/0113892029300608240531111743","volume":"25","author":"Z Peng","year":"2024","unstructured":"Peng Z, Fang C, Tong Z, Rao Q, Ren Z, Hu K. Crosstalk between cancer-associated fibroblasts and myeloid cells shapes the heterogeneous microenvironment of gastric cancer. Curr Genomics. 2024;25(5):390\u2013411. https:\/\/doi.org\/10.2174\/0113892029300608240531111743.","journal-title":"Curr Genomics"},{"issue":"3","key":"5067_CR11","doi-asserted-by":"publisher","first-page":"194","DOI":"10.2174\/0109298665350654250111144722","volume":"32","author":"Q Suyila","year":"2025","unstructured":"Suyila Q, Li X, Su X. Anti-cancer bioactive peptide induces apoptosis in gastric cancer cells through TP53 signaling cascade. Protein Pept Lett. 2025;32(3):194\u2013205. https:\/\/doi.org\/10.2174\/0109298665350654250111144722.","journal-title":"Protein Pept Lett"},{"key":"5067_CR12","doi-asserted-by":"publisher","DOI":"10.2174\/0118761429322420241112051105","volume":"17","author":"S Fatima","year":"2024","unstructured":"Fatima S, Song Y, Zhang Z, et al. Exploring the pharmacological mechanisms of P-hydroxylcinnamaldehyde for treating gastric cancer: a pharmacological perspective with experimental confirmation. Curr Mol Pharmacol. 2024;17:e18761429322420. https:\/\/doi.org\/10.2174\/0118761429322420241112051105.","journal-title":"Curr Mol Pharmacol"},{"key":"5067_CR13","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2025-012069","author":"P Zhang","year":"2025","unstructured":"Zhang P, Zhang M, Liu J, et al. Mitochondrial pathway signature (MitoPS) predicts immunotherapy response and reveals NDUFB10 as a key immune regulator in lung adenocarcinoma. J Immunother Cancer. 2025. https:\/\/doi.org\/10.1136\/jitc-2025-012069.","journal-title":"J Immunother Cancer"},{"issue":"5","key":"5067_CR14","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nmeth.3337","volume":"12","author":"AM Newman","year":"2015","unstructured":"Newman AM, Liu CL, Green MR, et al. Robust enumeration of cell subsets from tissue expression profiles. Nat Methods. 2015;12(5):453\u20137. https:\/\/doi.org\/10.1038\/nmeth.3337.","journal-title":"Nat Methods"},{"issue":"12","key":"5067_CR15","doi-asserted-by":"publisher","first-page":"3389","DOI":"10.1002\/ijc.32384","volume":"145","author":"J Bornschein","year":"2019","unstructured":"Bornschein J, Wernisch L, Secrier M, et al. Transcriptomic profiling reveals three molecular phenotypes of adenocarcinoma at the gastroesophageal junction. Int J Cancer. 2019;145(12):3389\u2013401. https:\/\/doi.org\/10.1002\/ijc.32384.","journal-title":"Int J Cancer"},{"key":"5067_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-9-559","volume":"9","author":"P Langfelder","year":"2008","unstructured":"Langfelder P, Horvath S. WGCNA: an R package for weighted correlation network analysis. BMC Bioinformatics. 2008;9:559. https:\/\/doi.org\/10.1186\/1471-2105-9-559.","journal-title":"BMC Bioinformatics"},{"issue":"9","key":"5067_CR17","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1111\/jcpe.12433","volume":"42","author":"J Coat","year":"2015","unstructured":"Coat J, Demoersman J, Beuzit S, et al. Anti-B lymphocyte immunotherapy is associated with improvement of periodontal status in subjects with rheumatoid arthritis. J Clin Periodontol. 2015;42(9):817\u201323. https:\/\/doi.org\/10.1111\/jcpe.12433.","journal-title":"J Clin Periodontol"},{"issue":"3","key":"5067_CR18","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1002\/jso.20218","volume":"90","author":"JR Siewert","year":"2005","unstructured":"Siewert JR, Feith M, Stein HJ. Biologic and clinical variations of adenocarcinoma at the esophago-gastric junction: relevance of a topographic-anatomic subclassification. J Surg Oncol. 2005;90(3):139\u201346. https:\/\/doi.org\/10.1002\/jso.20218.","journal-title":"J Surg Oncol"},{"issue":"9","key":"5067_CR19","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1093\/jjco\/hyad070","volume":"53","author":"C Katada","year":"2023","unstructured":"Katada C, Yokoyama T, Mure K, et al. Risk factors for the development of second primary esophageal squamous-cell carcinoma after endoscopic resection for esophageal squamous-cell carcinoma according to genetic polymorphisms related to alcohol and nicotine metabolism. Jpn J Clin Oncol. 2023;53(9):774\u201380. https:\/\/doi.org\/10.1093\/jjco\/hyad070.","journal-title":"Jpn J Clin Oncol"},{"issue":"1","key":"5067_CR20","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1124\/dmd.121.000642","volume":"50","author":"AG Bart","year":"2022","unstructured":"Bart AG, Morais G, Vangala VR, Loadman PM, Pors K, Scott EE. Cytochrome P450 binding and bioactivation of tumor-targeted duocarmycin agents. Drug Metab Dispos. 2022;50(1):49\u201357. https:\/\/doi.org\/10.1124\/dmd.121.000642.","journal-title":"Drug Metab Dispos"},{"issue":"12","key":"5067_CR21","doi-asserted-by":"publisher","DOI":"10.3390\/cells14120928","volume":"14","author":"Y Lin","year":"2025","unstructured":"Lin Y, Zhao X, Du Z, et al. MicroRNA miR-193b-3p regulates esophageal cancer progression through targeting RSF1. Cells. 2025;14(12): 928. https:\/\/doi.org\/10.3390\/cells14120928.","journal-title":"Cells"},{"issue":"1","key":"5067_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/s12929-025-01121-1","volume":"32","author":"HL Ho","year":"2025","unstructured":"Ho HL, Lin SC, Chiang CW, et al. miR-193b-3p suppresses lung cancer cell migration and invasion through PRNP targeting. J Biomed Sci. 2025;32(1):28. https:\/\/doi.org\/10.1186\/s12929-025-01121-1.","journal-title":"J Biomed Sci"},{"issue":"2","key":"5067_CR23","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1007\/s12539-020-00366-8","volume":"12","author":"J Qi","year":"2020","unstructured":"Qi J, Zhou J, Tang XQ, Wang Y. Gene biomarkers derived from clinical data of hepatocellular carcinoma. Interdiscip Sci. 2020;12(2):226\u201336. https:\/\/doi.org\/10.1007\/s12539-020-00366-8.","journal-title":"Interdiscip Sci"},{"issue":"24","key":"5067_CR24","doi-asserted-by":"publisher","first-page":"18291","DOI":"10.1074\/jbc.M110.106575","volume":"285","author":"T Wu","year":"2010","unstructured":"Wu T, Zhang X, Huang X, Yang Y, Hua X. Regulation of cyclin B2 expression and cell cycle G2\/m transition by menin. J Biol Chem. 2010;285(24):18291\u2013300. https:\/\/doi.org\/10.1074\/jbc.M110.106575.","journal-title":"J Biol Chem"},{"key":"5067_CR25","doi-asserted-by":"publisher","first-page":"6673","DOI":"10.2147\/ott.S171716","volume":"11","author":"HP Zhang","year":"2018","unstructured":"Zhang HP, Li SY, Wang JP, Lin J. Clinical significance and biological roles of cyclins in gastric cancer. Onco Targets Ther. 2018;11:6673\u201385. https:\/\/doi.org\/10.2147\/ott.S171716.","journal-title":"Onco Targets Ther"},{"issue":"44","key":"5067_CR26","doi-asserted-by":"publisher","first-page":"76329","DOI":"10.18632\/oncotarget.19357","volume":"8","author":"D Stahl","year":"2017","unstructured":"Stahl D, Braun M, Gentles AJ, et al. Low BUB1 expression is an adverse prognostic marker in gastric adenocarcinoma. Oncotarget. 2017;8(44):76329\u201339. https:\/\/doi.org\/10.18632\/oncotarget.19357.","journal-title":"Oncotarget"},{"issue":"12","key":"5067_CR27","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1111\/crj.13717","volume":"17","author":"D Yin","year":"2023","unstructured":"Yin D, Zhang Y, Li H, Cheng L. Association of TOP2A and ADH1B with lipid levels and prognosis in patients with lung adenocarcinoma and squamous cell carcinoma. Clin Respir J. 2023;17(12):1301\u201315. https:\/\/doi.org\/10.1111\/crj.13717.","journal-title":"Clin Respir J"},{"issue":"34","key":"5067_CR28","doi-asserted-by":"publisher","first-page":"57574","DOI":"10.18632\/oncotarget.15895","volume":"8","author":"M Terashima","year":"2017","unstructured":"Terashima M, Ichikawa W, Ochiai A, et al. TOP2A, GGH, and PECAM1 are associated with hematogenous, lymph node, and peritoneal recurrence in stage II\/III gastric cancer patients enrolled in the ACTS-GC study. Oncotarget. 2017;8(34):57574\u201382. https:\/\/doi.org\/10.18632\/oncotarget.15895.","journal-title":"Oncotarget"},{"issue":"3","key":"5067_CR29","doi-asserted-by":"publisher","first-page":"205","DOI":"10.7888\/juoeh.33.205","volume":"33","author":"T Hanagiri","year":"2011","unstructured":"Hanagiri T, Ono K, Kuwata T, et al. Evaluation of topoisomerase I\/topoisomerase IIalpha status in esophageal cancer. J UOEH. 2011;33(3):205\u201316. https:\/\/doi.org\/10.7888\/juoeh.33.205.","journal-title":"J UOEH"},{"issue":"18","key":"5067_CR30","doi-asserted-by":"publisher","first-page":"1958","DOI":"10.1080\/15384101.2022.2078458","volume":"21","author":"M Murph","year":"2022","unstructured":"Murph M, Singh S, Schvarzstein M. A combined in silico and in vivo approach to the structure-function annotation of SPD-2 provides mechanistic insight into its functional diversity. Cell Cycle. 2022;21(18):1958\u201379. https:\/\/doi.org\/10.1080\/15384101.2022.2078458.","journal-title":"Cell Cycle"},{"issue":"1","key":"5067_CR31","doi-asserted-by":"publisher","DOI":"10.1080\/15384047.2023.2287122","volume":"25","author":"Y Chen","year":"2024","unstructured":"Chen Y, Chen Y, Liu W. Chaperonin containing TCP1 subunit 6A may activate Notch and Wnt pathways to facilitate the malignant behaviors and cancer stemness in oral squamous cell carcinoma. Cancer Biol Ther. 2024;25(1):2287122. https:\/\/doi.org\/10.1080\/15384047.2023.2287122.","journal-title":"Cancer Biol Ther"},{"issue":"8","key":"5067_CR32","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1016\/j.annonc.2020.04.011","volume":"31","author":"S Derks","year":"2020","unstructured":"Derks S, de Klerk LK, Xu X, et al. Characterizing diversity in the tumor-immune microenvironment of distinct subclasses of gastroesophageal adenocarcinomas. Ann Oncol. 2020;31(8):1011\u201320. https:\/\/doi.org\/10.1016\/j.annonc.2020.04.011.","journal-title":"Ann Oncol"},{"key":"5067_CR33","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.ejca.2023.01.022","volume":"183","author":"I Porth","year":"2023","unstructured":"Porth I, Hirsch D, Ceribas Y, et al. Comprehensive biomarker analysis of long-term response to trastuzumab in patients with HER2-positive advanced gastric or gastroesophageal adenocarcinoma. Eur J Cancer. 2023;183:119\u201330. https:\/\/doi.org\/10.1016\/j.ejca.2023.01.022.","journal-title":"Eur J Cancer"},{"key":"5067_CR34","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.640080","volume":"11","author":"Y Wang","year":"2021","unstructured":"Wang Y, Sun H, Zhu N, et al. Myeloid-derived suppressor cells in immune microenvironment promote progression of esophagogastric junction adenocarcinoma. Front Oncol. 2021;11:640080. https:\/\/doi.org\/10.3389\/fonc.2021.640080.","journal-title":"Front Oncol"},{"issue":"1","key":"5067_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/s41746-025-02172-2","volume":"8","author":"Z Gong","year":"2025","unstructured":"Gong Z, Du M, Li Y, et al. Machine learning identifies TIME subtypes linking EGFR mutations and immune states in lung adenocarcinoma. NPJ Digit Med. 2025;8(1):796. https:\/\/doi.org\/10.1038\/s41746-025-02172-2.","journal-title":"NPJ Digit Med"},{"issue":"3","key":"5067_CR36","doi-asserted-by":"publisher","first-page":"2650","DOI":"10.1007\/s10528-024-10840-3","volume":"63","author":"W Zhang","year":"2025","unstructured":"Zhang W, Dong J, Wu Y, Liang X, Suo L, Wang L. Integrated bioinformatic analysis reveals the oncogenic, survival, and prognostic characteristics of TPX2 in hepatocellular carcinoma. Biochem Genet. 2025;63(3):2650\u201372. https:\/\/doi.org\/10.1007\/s10528-024-10840-3.","journal-title":"Biochem Genet"},{"issue":"1","key":"5067_CR37","doi-asserted-by":"publisher","first-page":"9","DOI":"10.7150\/jca.76809","volume":"14","author":"Y Shi","year":"2023","unstructured":"Shi Y, Sang X, Deng J, et al. Six cell cycle-related genes serve as potential prognostic biomarkers and correlated with immune infiltrates in hepatocellular carcinoma. J Cancer. 2023;14(1):9\u201323. https:\/\/doi.org\/10.7150\/jca.76809.","journal-title":"J Cancer"},{"key":"5067_CR38","doi-asserted-by":"publisher","DOI":"10.3389\/fbinf.2022.871027","volume":"2","author":"S Tan","year":"2022","unstructured":"Tan S, Chen W, Kong G, Wei L. ASPM may be related to the malignant progression of hepatitis B and is associated with a poor prognosis of hepatocellular carcinoma. Front Bioinform. 2022;2:871027. https:\/\/doi.org\/10.3389\/fbinf.2022.871027.","journal-title":"Front Bioinform"},{"key":"5067_CR39","doi-asserted-by":"publisher","DOI":"10.1155\/2024\/5058607","volume":"2024","author":"Y Yu","year":"2024","unstructured":"Yu Y, Ma S, Zhou J. Identification of hub genes for psoriasis and cancer by bioinformatic analysis. Biomed Res Int. 2024;2024:5058607. https:\/\/doi.org\/10.1155\/2024\/5058607.","journal-title":"Biomed Res Int"},{"issue":"1","key":"5067_CR40","doi-asserted-by":"publisher","DOI":"10.1038\/s41698-023-00461-1","volume":"7","author":"SB Lee","year":"2023","unstructured":"Lee SB, Pan J, Xiong D, et al. Striking efficacy of a vaccine targeting TOP2A for triple-negative breast cancer immunoprevention. NPJ Precis Oncol. 2023;7(1):108. https:\/\/doi.org\/10.1038\/s41698-023-00461-1.","journal-title":"NPJ Precis Oncol"},{"issue":"1","key":"5067_CR41","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1002\/mdr2.70004","volume":"1","author":"H Zhang","year":"2025","unstructured":"Zhang H, Zhang G, Xu P, et al. Optimized dynamic network biomarker deciphers a high-resolution heterogeneity within thyroid cancer molecular subtypes. Med Res. 2025;1(1):10\u201331. https:\/\/doi.org\/10.1002\/mdr2.70004.","journal-title":"Med Res"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-026-05067-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-026-05067-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-026-05067-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T02:43:15Z","timestamp":1782960195000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-026-05067-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,9]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5067"],"URL":"https:\/\/doi.org\/10.1007\/s12672-026-05067-0","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,9]]},"assertion":[{"value":"10 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All data used in this study were sourced from publicly available databases GEO (\n                      \n                      ).\n                      These data have undergone ethical review by the original data collection institution and have been de-identified to protect patient privacy. According to relevant ethical regulations, such secondary analysis based on public data does not require additional ethical approval.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"971"}}